Takeda's Dengue Shot is 80% Effective in Phase III Trial

November 28, 2019

Takeda's Dengue Shot is 80% Effective in Phase III Trial

Takeda has released results from a clinical trial that found its dengue shot was 95.4% effective in preventing dengue that required hospitalization; there were five hospitalizations in the vaccine group versus 53 in the placebo group. The company will submit these phase III results for regulatory approval. With clinical trials taking place in more than 200 countries worldwide, Yourway is the partner that companies need to navigate the diverse and ever-changing global regulatory landscape.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 11-13, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Just-in-Time or Plan Ahead? Mastering Logistics Strategies for Complex Clinical Trials

Open chat

Hello! How can I help you?